EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   1.8.1.B1 | Infections |
26767257 |
[Study on immunologic function of thioredoxin glutathione reductase from Schistosoma japonicum]. |
ongoing research
therapeutic application
unassigned |
3
2
0 |
| 1.8.1.B1 | Infections |
27238582 |
Unusual thiol-based redox metabolism of parasitic flukes. |
therapeutic application
unassigned |
4
0 |
| 1.8.1.B1 | Malaria |
22177949 |
Investigation of a potential mechanism for the inhibition of SmTGR by Auranofin and its implications for Plasmodium falciparum inhibition. |
ongoing research
unassigned |
1
0 |
| 1.8.1.B1 | Schistosomiasis |
20659890 |
Mapping the catalytic cycle of Schistosoma mansoni thioredoxin glutathione reductase by X-ray crystallography. |
causal interaction
therapeutic application
unassigned |
2
4
0 |
| 1.8.1.B1 | Schistosomiasis |
21630672 |
Investigations of the catalytic mechanism of thioredoxin glutathione reductase from Schistosoma mansoni. |
causal interaction
therapeutic application
unassigned |
3
4
0 |
| 1.8.1.B1 | Schistosomiasis |
24397869 |
Proteomic profiling of nitrosative stress: protein s-oxidation accompanies s-nitrosylation. |
ongoing research
therapeutic application
unassigned |
4
1
0 |
| 1.8.1.B1 | Schistosomiasis |
26341081 |
High-throughput screening against thioredoxin glutathione reductase identifies novel inhibitors with potential therapeutic value for schistosomiasis. |
diagnostic usage
therapeutic application
unassigned |
1
4
0 |
| 1.8.1.B1 | Schistosomiasis |
29800515 |
Fragment-Based Discovery of a Regulatory Site in Thioredoxin Glutathione Reductase Acting as "Doorstop" for NADPH Entry. |
therapeutic application
unassigned |
4
0 |
| 1.8.1.B1 | Schistosomiasis |
31939288 |
Characterization of Lead Compounds Targeting the Selenoprotein Thioredoxin Glutathione Reductase for Treatment of Schistosomiasis. |
unassigned |
0 |
| 1.8.1.B1 | Schistosomiasis |
32451992 |
Computer-Aided Drug Design for the Identification of Novel Antischistosomal Compounds. |
therapeutic application
unassigned |
3
0 |
